User profiles for G Biasco

biasco g

Professor
Verified email at unibo.it
Cited by 10334

[HTML][HTML] c-Met as a target for personalized therapy

I Garajová, E Giovannetti, G Biasco… - Translational …, 2015 - ncbi.nlm.nih.gov
MET and its ligand HGF are involved in many biological processes, both physiological and
pathological, making this signaling pathway an attractive therapeutic target in oncology. …

Metastatic pancreatic cancer: is gemcitabine still the best standard treatment?

…, S Vecchiarelli, G Brandi, G Biasco - Oncology …, 2010 - spandidos-publications.com
Pancreatic ductal adenocarcinoma is the fourth cause of death in the Western world.
Surgery remains the only treatment offering an advantage in terms of overall survival (5-year …

Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives

…, A Maleddu, A Astolfi, S Formica, G Biasco - Cancer treatment …, 2009 - Elsevier
Nowadays molecular biology represents one of the most interesting topics in medical
oncology, because it provides a global and detailed view on the molecular changes involved in …

[HTML][HTML] Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto …

…, G D'Ambrosio, L Boni, M Di Biase, G Biasco… - Journal of the American …, 1995 - Elsevier
Objectives. This study was performed to evaluate the effects of l-carnitine administration on
long-term left ventricular dilation in patients with acute anterior myocardial infarction. …

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells

…, G Lazzarini, E Spisni, MA Pantaleo, G Biasco… - Experimental cell …, 2009 - Elsevier
… Cell lysates were incubated 1 h on ice and centrifuged at 12 000 g to collect supernatants.
After addition of SDS-PAGE sample buffer and boiling, 40 μg of denatured proteins were …

The 'surprise'question in advanced cancer patients: a prospective study among general practitioners

…, M Salera, FG Dall'Olio, G Galli, G Biasco… - Palliative …, 2014 - journals.sagepub.com
Background: Using the ‘surprise’ question ‘Would you be surprised if this patient died in the
next year?’ may improve physicians’ prognostic accuracy and identify people appropriate for …

[HTML][HTML] Hypersensitivity reactions related to oxaliplatin (OHP)

…, P Mordenti, MC Di Marco, G Biasco - British journal of …, 2003 - nature.com
Patients treated with platinum compounds are subject to hypersensitivity reactions. Our study
has highlighted the reactions related to oxaliplatin (OHP) infusion. One hundred and twenty…

SDHA Loss-of-Function Mutations in KITPDGFRA Wild-Type Gastrointestinal Stromal Tumors Identified by Massively Parallel …

…, R Casadio, A Pession, G Biasco - Journal of the …, 2011 - academic.oup.com
… Massively parallel sequencing analysis revealed that GIST_07 had a C to G transversion
at nucleotide 1151 in exon 9 of SDHA , a nonsense mutation resulting in the replacement of …

Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib

…, CC Williams Jr, E Fumagalli, G Biasco… - Cancer, 2015 - Wiley Online Library
BACKGROUND The objectives of this study were to provide sunitinib to patients with
gastrointestinal stromal tumor (GIST) who were otherwise unable to obtain it and to collect broad …

Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review

…, D Santini, M Pantaleo, G Biasco, G Caletti… - Journal of …, 2008 - Elsevier
Background Although the feasibility of laparoscopic resection of gastric gastrointestinal stromal
tumors (GISTs) has been established, various aspects are debated. This paper describes …